Progen

Developer of immunotherapies for immune diseases and cancer

placeSeoul, Seoul, South Korea calendar_todayFounded 2000 language progen.co.kr

Registered entities

Innovation

28 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 402 times.

YearFilings
20121
20132
20161
20174
20181
20197
20203
20219
20226
20233
20244
20261

Investor mix

1 investor on record; lead investors include Yuhan Corporation.

Investor typeCountShare
Other / undisclosed1100%
Coming soon